# Sight Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sight-sciences

- Industry: Medical Devices & Equipment
- Headquarters: Menlo Park, US
- Website: www.sightsciences.com
- Total disclosed funding: $87M
- Latest round: Series F (Nov 23, 2020)
- Investors on record: 5

## About

Based in California, US, and founded in 2011 by co-founders David Badawi and Paul Badawi, Sight Sciences, Inc. operates as a medical device company that develops eye treatment devices for glaucoma. The company has 169 employees as of June 2021. Sight Sciences has raised a total of USD 108.7 million in funding. It is backed by Allegro Investment Fund, KCK Group, MidCap Financial, and D1 Capital Partners. The company released its IPO in July 2021 and is listed on Nasdaq under the ticker symbol SGHT. The company has 184 employees.

The company develops engineered products to target glaucoma and dry eye disease through minimally invasive or non-invasive approaches. The company's OMNI surgical system is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG) which causes irreversible blindness. Sight Sciences provides a TearCare® System which is a wearable, office-based thermal eyelid technology that enables the controlled application of localized heat to the eyelids to relieve dry eye disease.

Sight Sciences generated USD 30 million in revenue from March 2020 to March 2021.

## Funding rounds

- Series F, Nov 23, 2020, $23M — D1 Capital Partners, Janus Henderson Investors
- Series E, Mar 17, 2020, $30M — D1 Capital Partners
- Series C, May 31, 2018, $9.7M — Allegro Investment Fund
- Series C, Jul 7, 2017, $10M — Allegro Investment Fund
- Series B, Mar 15, 2016, $7M — Hicks Equity Partners, Scientific Health Development, Allegro Investment Fund
- Series A, Oct 30, 2015, $6.9M — Scientific Health Development, Allegro Investment Fund

## Investors

- Scientific Health Development (https://capitalatlas.ai/funds/scientific-health-development) — Series A, Series B
- Allegro Investment Fund — Series A, Series B, Series C
- Hicks Equity Partners (https://capitalatlas.ai/funds/hicks-equity-partners) — Series B
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series E, Series F
- Janus Henderson Investors — Series F